An oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in vitro

European Journal of Cancer Prevention

Volumn 19, Issue 1, 2010, Pages 61-67

  Mu, Rong ^a   Lu, Na ^a   Wang, Jia ^a   Yin, Yueheng ^a   Ding, Yan ^a   Zhang, Xiaoxuan ^a   Gui, Huan ^a   Sun, Qiong ^a   Duan, Huaqin ^a   Zhang, Lun ^a   Zhang, Yuchen ^a   Ke, Xue ^a   Guo, Qinglong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Analogue; Apoptosis; Cancer; Gambogic acid

Indexed keywords

CASPASE 3; GAMBOGIC ACID; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CELL CYCLE ARREST; CELL VIABILITY; CHROMATIN; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPE; GROWTH INHIBITION; HUMAN; IN VITRO STUDY; LIVER CELL CARCINOMA; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; DRUG EVALUATION, PRECLINICAL; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; XANTHONES;

EID: 75149119328     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328333fb22     Document Type: Article

References (33)

1. Adams JM, Cory S (2007). The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324-1337.
2. Afford S, Randhawa S (2000). Apoptosis. Mol Pathol 53:55-63.
3. Ashe PC, Berry MD (2003). Apoptotic signaling cascades. Prog Neuropsychopharmacol Biol Psychiatry 27:199-214.
4. Bouchier-Hayes L, Munoz-Pinedo C, Connell S, Green DR (2008). Measuring apoptosis at the single cell level. Methods 44:222-228.
5. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501.
6. Burlacu A (2003). Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7:249-257.
7. Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ (2002). Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 99:6252-6256.
8. Daniel B, De Coster MA (2004). Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining. Brain Res Brain Res Protoc 13:144-150.
9. Earnshaw WC, Martins LM, Kaufmann SH (1999). Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424.
10. Gao CF, Ren S, Zhang L, Nakajima T, Ichinose S, Hara T, et al. (2001). Caspasedependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis. Exp Cell Res 265:145-151.
11. Ghobrial IM,Witzig TE, Adjei AA (2005). Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55:178-194.
12. Guo QL, You QD, Wu ZQ, Yuan ST, Zhao L (2004). General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol Sin 25:769-774.
13. Guo QL, Lin SS, You QD, Gu HY, Yu J, Zhao L, et al. (2006). Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. Life Sci 78:1238-1245.
14. Heimlich G, McKinnon AD, Bernardo K, Brdiczka D, Reed JC, Kain R, et al. (2004). Bax-induced cytochrome c release from mitochondria depends on alpha-helices-5 and -6. Biochem J 378:247-255.
15. Kasibhatla S, Jessen KA, Maliartchouk S, Wang JY, English NM, Drewe J, et al. (2005). A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci USA 102:12095-12100.
16. Kerr JF, Wyllie AH, Currie AR (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 2 6:239-257.
17. Liu W, Guo QL, You QD, Zhao L, Gu HY, Yuan ST (2005). Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC- 8 23. World J Gastroenterol 11:3655-3659.
18. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, et al. (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1 82:1545-1556.
19. Mazumder S, Plesca D, Almasan A (2008). Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol 4 14:13-21.
20. Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 6 5:55-63.
21. Oancea M, Mazumder S, Crosby ME, Almasan A (2006). Apoptosis assays. Methods Mol Med 129:279-290.
22. Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB (2007). Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood 110:3517-3525.
23. Papazoglu C, Mills AA (2007). p53: at the crossroad between cancer and ageing. J Pathol 211:124-133.
24. Pettersson F, Colston KW, Dalgleish AG (2000). Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro. Br J Cancer 83:239-245.
25. Pettersson F, Colston KW, Dalgleish AG (2001). Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells. Pancreas 23:273-279.
26. Pettersson F, Dalgleish AG, Bissonnette RP, Colston KW (2002). Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br J Cancer 87:555-561.
27. Qin Y, Meng L, Hu C, Duan W, Zuo Z, Lin L, et al. (2007). Gambogic acid inhibits the catalytic activity of human topoisomerase II alpha by binding to its ATPase domain. Mol Cancer Ther 6:2429-2440.
28. Reed JC (1997). Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 34:9-19.
29. Tamm I, Schriever F, Dorken B (2001). Apoptosis: implications of basic research for clinical oncology. Lancet Oncol 2:33-42.
30. Wang J, Zhao L, Hu Y, Guo Q, Zhang L, Wang X, et al. (2009). Studies on chemical structure modification and biology of a natural product, gambogic acid (I): Synthesis and biological evaluation of oxidized analogues of gambogic acid. Eur J Med Chem 44:2611-2620.
31. Wyllie AH, Kerr JF, Currie AR (1980). Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306.
32. Yu J, Guo QL, You QD, Lin SS, Li Z, Gu HY, et al. (2006). Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother Pharmacol 5 8:434-443.
33. Zhao L, Guo QL, You QD, Wu ZQ, Gu HY (2004). Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol Pharm Bull 27:998-1003.